Key issues in the diagnosis and treatment of multiple sclerosis. An overview.
O'Connor
Paul
P
Division of Neurology, St. Michael's Hospital, 30 Bond Street, Suite 3 007 Shuter Wing, Toronto, Ontario, Canada M5B 1W8. oconnorp@smh.toronto.on.ca
D002986:Clinical Trials as Topic; D018450:Disease Progression; D000068717:Glatiramer Acetate; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D008942:Mitoxantrone / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D010455:Peptides / Q000627:therapeutic use
D016756:Immunoglobulins, Intravenous; D010455:Peptides; D000068576:Interferon beta-1b; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D008942:Mitoxantrone; D008775:Methylprednisolone; D000068556:Interferon beta-1a